Review



polyclonal goat anti ipo13  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Novus Biologicals polyclonal goat anti ipo13
    Polyclonal Goat Anti Ipo13, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal goat anti ipo13/product/Novus Biologicals
    Average 90 stars, based on 15 article reviews
    polyclonal goat anti ipo13 - by Bioz Stars, 2026-06
    90/100 stars

    Images



    Similar Products

    cited-2 antibody (ja22) - bsa free  (Bio-Techne corporation)
    90
    Bio-Techne corporation cited-2 antibody (ja22) - bsa free
    Cited 2 Antibody (Ja22) Bsa Free, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cited-2 antibody (ja22) - bsa free/product/Bio-Techne corporation
    Average 90 stars, based on 1 article reviews
    cited-2 antibody (ja22) - bsa free - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    polyclonal goat anti ipo13  (Novus Biologicals)
    90
    Novus Biologicals polyclonal goat anti ipo13
    Polyclonal Goat Anti Ipo13, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal goat anti ipo13/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    polyclonal goat anti ipo13 - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    polyclonal goat anti ipo13 antibody  (Novus Biologicals)
    90
    Novus Biologicals polyclonal goat anti ipo13 antibody
    Figure 1. Representative immunohistochemical staining patterns of <t>IPO13</t> in human proliferative phase endometrium, secretory phase
    Polyclonal Goat Anti Ipo13 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal goat anti ipo13 antibody/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    polyclonal goat anti ipo13 antibody - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    anti-ipo13 goat polyclonal antibody nb100-1369  (Novus Biologicals)
    90
    Novus Biologicals anti-ipo13 goat polyclonal antibody nb100-1369
    Figure 1. Representative immunohistochemical staining patterns of <t>IPO13</t> in human proliferative phase endometrium, secretory phase
    Anti Ipo13 Goat Polyclonal Antibody Nb100 1369, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-ipo13 goat polyclonal antibody nb100-1369/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    anti-ipo13 goat polyclonal antibody nb100-1369 - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    anti ipo13 goat polyclonal antibody  (Novus Biologicals)
    90
    Novus Biologicals anti ipo13 goat polyclonal antibody
    The expression levels of <t>IPO13</t> and caspase3 in the endometrial tissues were detected by immunohistochemistry (400×). ( A ) Control endometrium at the proliferation phase. ( B ) Control endometrium at the secretion phase. ( C ) EP at the proliferation phase. ( D ) EP at the secretion phase. ( E ) Control endometrium at the proliferation phase. ( F ) Control endometrium at the secretion phase. ( G ) EP at the proliferation phase. ( H ) EP at the secretion phase. * p<0.05 ( vs. control endometrium at the proliferation phase); ** p<0.05 ( vs. control endometrium at the secretion phase); error bars, SEM.
    Anti Ipo13 Goat Polyclonal Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti ipo13 goat polyclonal antibody/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    anti ipo13 goat polyclonal antibody - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 1. Representative immunohistochemical staining patterns of IPO13 in human proliferative phase endometrium, secretory phase

    Journal: Medical science monitor : international medical journal of experimental and clinical research

    Article Title: Increased expression of importin13 in endometriosis and endometrial carcinoma.

    doi: 10.12659/msm.882879

    Figure Lengend Snippet: Figure 1. Representative immunohistochemical staining patterns of IPO13 in human proliferative phase endometrium, secretory phase

    Article Snippet: Next, polyclonal goat anti-IPO13 antibody (1:100; NB100-1369; Novus Biologicals) was applied to the tissue sections at 4° overnight.

    Techniques: Immunohistochemical staining, Staining

    Figure 3. Co-localization of IPO13 and CD90,

    Journal: Medical science monitor : international medical journal of experimental and clinical research

    Article Title: Increased expression of importin13 in endometriosis and endometrial carcinoma.

    doi: 10.12659/msm.882879

    Figure Lengend Snippet: Figure 3. Co-localization of IPO13 and CD90,

    Article Snippet: Next, polyclonal goat anti-IPO13 antibody (1:100; NB100-1369; Novus Biologicals) was applied to the tissue sections at 4° overnight.

    Techniques:

    Figure 4. Co-localization of IPO13, telomerase,

    Journal: Medical science monitor : international medical journal of experimental and clinical research

    Article Title: Increased expression of importin13 in endometriosis and endometrial carcinoma.

    doi: 10.12659/msm.882879

    Figure Lengend Snippet: Figure 4. Co-localization of IPO13, telomerase,

    Article Snippet: Next, polyclonal goat anti-IPO13 antibody (1:100; NB100-1369; Novus Biologicals) was applied to the tissue sections at 4° overnight.

    Techniques:

    Figure 6. Western blot analysis of IPO13 in human endometrium,

    Journal: Medical science monitor : international medical journal of experimental and clinical research

    Article Title: Increased expression of importin13 in endometriosis and endometrial carcinoma.

    doi: 10.12659/msm.882879

    Figure Lengend Snippet: Figure 6. Western blot analysis of IPO13 in human endometrium,

    Article Snippet: Next, polyclonal goat anti-IPO13 antibody (1:100; NB100-1369; Novus Biologicals) was applied to the tissue sections at 4° overnight.

    Techniques: Western Blot

    The expression levels of IPO13 and caspase3 in the endometrial tissues were detected by immunohistochemistry (400×). ( A ) Control endometrium at the proliferation phase. ( B ) Control endometrium at the secretion phase. ( C ) EP at the proliferation phase. ( D ) EP at the secretion phase. ( E ) Control endometrium at the proliferation phase. ( F ) Control endometrium at the secretion phase. ( G ) EP at the proliferation phase. ( H ) EP at the secretion phase. * p<0.05 ( vs. control endometrium at the proliferation phase); ** p<0.05 ( vs. control endometrium at the secretion phase); error bars, SEM.

    Journal: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research

    Article Title: The expression levels of stem cell markers importin13, c-kit, CD146, and telomerase are decreased in endometrial polyps

    doi: 10.12659/MSM.881901

    Figure Lengend Snippet: The expression levels of IPO13 and caspase3 in the endometrial tissues were detected by immunohistochemistry (400×). ( A ) Control endometrium at the proliferation phase. ( B ) Control endometrium at the secretion phase. ( C ) EP at the proliferation phase. ( D ) EP at the secretion phase. ( E ) Control endometrium at the proliferation phase. ( F ) Control endometrium at the secretion phase. ( G ) EP at the proliferation phase. ( H ) EP at the secretion phase. * p<0.05 ( vs. control endometrium at the proliferation phase); ** p<0.05 ( vs. control endometrium at the secretion phase); error bars, SEM.

    Article Snippet: Anti-IPO13 goat polyclonal antibody (1:100, NB100-1369, Novus Biologicals), anti-telomerase rabbit polyclonal antibody (1: 100, ZA-0239, Beijing Golden Bridge Biotechnology Co., Ltd.), anti-CD146 mouse monoclonal antibody (1:50, ZM-0299, Beijing Golden Bridge Biotechnology Co., Ltd.), anti-caspase3 rabbit polyclonal antibody (1:100, BS1518, Bioworld Technology, Inc.), anti-bax rabbit polyclonal antibody (1:100, BS1725, Bioworld Technology, Inc.) and anti-bcl-2 rabbit monoclonal antibody (1:100, bs-0522R, Bioworld Technology, Inc.) were incubated with the sections overnight at 4°C.

    Techniques: Expressing, Immunohistochemistry, Control

    The mRNA expression of IPO13, c-kit, bcl-2 and bax was detected by real-time PCR. (A) Control endometrium at the proliferation phase. (IB) Control endometrium at the secretion phase. (IC) EP at the proliferation phase. (ID) EP at the secretion phase. (IIA) Control endometrium at the proliferation phase. (IIB) Control endometrium at the secretion phase. (IIC) EP at the proliferation phase. (IID) EP at the secretion phase. (IIIA) Control endometrium at the proliferation phase. (IIIB) Control endometrium at the secretion phase. (IIIC) EP at the proliferation phase. (IIID) EP at the secretion phase. (IVA) Control endometrium at the proliferation phase. (IVB) Control endometrium at the secretion phase. (IVC) EP at the proliferation phase. (IVD) EP at the secretion phase. ** p<0.05 ( vs. control endometrium at the secretion phase); error bars, SEM.

    Journal: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research

    Article Title: The expression levels of stem cell markers importin13, c-kit, CD146, and telomerase are decreased in endometrial polyps

    doi: 10.12659/MSM.881901

    Figure Lengend Snippet: The mRNA expression of IPO13, c-kit, bcl-2 and bax was detected by real-time PCR. (A) Control endometrium at the proliferation phase. (IB) Control endometrium at the secretion phase. (IC) EP at the proliferation phase. (ID) EP at the secretion phase. (IIA) Control endometrium at the proliferation phase. (IIB) Control endometrium at the secretion phase. (IIC) EP at the proliferation phase. (IID) EP at the secretion phase. (IIIA) Control endometrium at the proliferation phase. (IIIB) Control endometrium at the secretion phase. (IIIC) EP at the proliferation phase. (IIID) EP at the secretion phase. (IVA) Control endometrium at the proliferation phase. (IVB) Control endometrium at the secretion phase. (IVC) EP at the proliferation phase. (IVD) EP at the secretion phase. ** p<0.05 ( vs. control endometrium at the secretion phase); error bars, SEM.

    Article Snippet: Anti-IPO13 goat polyclonal antibody (1:100, NB100-1369, Novus Biologicals), anti-telomerase rabbit polyclonal antibody (1: 100, ZA-0239, Beijing Golden Bridge Biotechnology Co., Ltd.), anti-CD146 mouse monoclonal antibody (1:50, ZM-0299, Beijing Golden Bridge Biotechnology Co., Ltd.), anti-caspase3 rabbit polyclonal antibody (1:100, BS1518, Bioworld Technology, Inc.), anti-bax rabbit polyclonal antibody (1:100, BS1725, Bioworld Technology, Inc.) and anti-bcl-2 rabbit monoclonal antibody (1:100, bs-0522R, Bioworld Technology, Inc.) were incubated with the sections overnight at 4°C.

    Techniques: Expressing, Real-time Polymerase Chain Reaction, Control

    The relative expression levels of IPO13 and bcl-2 proteins in normal endometrial and EP tissues.

    Journal: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research

    Article Title: The expression levels of stem cell markers importin13, c-kit, CD146, and telomerase are decreased in endometrial polyps

    doi: 10.12659/MSM.881901

    Figure Lengend Snippet: The relative expression levels of IPO13 and bcl-2 proteins in normal endometrial and EP tissues.

    Article Snippet: Anti-IPO13 goat polyclonal antibody (1:100, NB100-1369, Novus Biologicals), anti-telomerase rabbit polyclonal antibody (1: 100, ZA-0239, Beijing Golden Bridge Biotechnology Co., Ltd.), anti-CD146 mouse monoclonal antibody (1:50, ZM-0299, Beijing Golden Bridge Biotechnology Co., Ltd.), anti-caspase3 rabbit polyclonal antibody (1:100, BS1518, Bioworld Technology, Inc.), anti-bax rabbit polyclonal antibody (1:100, BS1725, Bioworld Technology, Inc.) and anti-bcl-2 rabbit monoclonal antibody (1:100, bs-0522R, Bioworld Technology, Inc.) were incubated with the sections overnight at 4°C.

    Techniques: Expressing, Control